Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XERO LIMITED Capital/Financing Update 2014

Sep 7, 2014

66106_rns_2014-09-07_7e4de785-e720-45b2-8977-ad112a122fa9.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule
2.7,
3.10.3,
3.10.4,
3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information
or
documents
not
available
now
must
be
given
to
ASX
as
soon
as
available.
Information
and documents
given
to
ASX
become
ASX’s
property
and
may
be
made
public.

Introduced
01/07/96
Origin:
Appendix
5
Amended
01/07/98,
01/09/99,
01/07/00,
30/09/01,
11/03/02,
01/01/03,
24/10/05,
01/08/12, 04/03/13

Name
of
entity

Xero
Limited

ABN

160
661
183
(ARBN)

We
(the
entity)
give
ASX
the
following
information.

Part 1 - All issues

You
must
complete
the
relevant
sections
(attach
sheets
if
there
is
not
enough
space).

1
+Class of+securities issued or to
be issued



2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued



3
Principal
terms
of
the
+securities
(e.g.
if
options,
exercise price and expiry date; if
partly
paid
+securities,
the
amount outstanding and due
dates
for
payment;
if
+convertible
securities,
the
conversion price and dates for
conversion)

Ordinary Shares
2,094
Ordinary Shares issued upon exercise of
vested options under the Xero Limited
(USA) Equity Incentive Scheme as part of
the remuneration package of US based
employees.

The exercise price for the exercise of the
options was as follows:

546 options at NZ$7.70 per option
1,548 options at NZ$17.40per option
4
Do the+securities rank equally
in all respects from the+issue
date with an existing+class of
quoted+securities?

If the additional+securities do
not rank equally, please state:
• the date from which they do
• the extent to which they
participate
for
the
next
dividend, (in the case of a
trust,
distribution)
or
interest payment
• the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment


5
Issue price or consideration



6
Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)








6a
Is the entity an+eligible entity
that
has
obtained
security
holder approval under rule 7.1A?

If Yes, complete sections 6b – 6h
in relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i


6b
The date the security holder
resolution under rule 7.1A was
passed


6c
Number of+securities issued
without security holder approval
under rule 7.1

Yes
Ordinary Shares issued upon exercise of
options; the exercise price for the exercise of
the options was as follows:

546 options at NZ$7.70 per option
1,548 options at NZ$17.40per option
Issue of Ordinary Shares on exercise of
vested options that have been granted under
the Xero Limited (USA) Equity Incentive
Scheme as part of the remuneration package
of US based employees.
N/A
N/A
N/A
  • See
    chapter
    19
    for
    defined
    terms.

Appendix
3B
Page
2

6d
Number of+securities issued
with security holder approval
under rule 7.1A


6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)



6f
Number of+securities issued
under an exception in rule 7.2


6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.


6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which
valuation
of
consideration was released to
ASX Market Announcements


6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements


7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.




8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the
+securities in
section 2 if applicable)




N/A
N/A
N/A
N/A
N/A
N/A
5 September 2014
Number +Class
127,856,877 Ordinary
Number +Class

9 Number and +class of all (a)
847,067 Options
(convertible +securities
not
quoted
on
ASX into
Ordinary
Shares ( including the +securities
in on
a
1:1
basis) section
2
if
applicable) (b)
67,085 Conditional contractual
right
to be issued up to 67,085 Ordinary Shares

  • 10 Dividend
    policy
    (in
    the
    case
    of
    a trust,
    distribution
    policy)
    on
    the increased
    capital
    (interests)

N/A

Part 2 - Pro rata issue

11
Is
security
holder
approval
required?



12
Is the issue renounceable or non-
renounceable?


13
Ratio in which the+securities
will be offered


14
+Class of+securities to which the
offer relates


15
+Record
date
to
determine
entitlements


16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?


17
Policy for deciding entitlements
in relation to fractions



18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See
    chapter
    19
    for
    defined
    terms.

Appendix
3B
Page
4

19
Closing
date
for
receipt
of
acceptances or renunciations


20
Names of any underwriters




21
Amount of any underwriting fee
or commission


22
Names of any brokers to the
issue




23
Fee or commission payable to
the broker to the issue


24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders


25
If the issue is contingent on
security holders’ approval, the
date of the meeting


26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled


27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders


28
Date rights trading will begin (if
applicable)


29
Date rights trading will end (if
applicable)




30
How do security holders sell
their entitlements_in full_through
a broker?


31
How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

32 How
do
security
holders
dispose of
their
entitlements
(except
by sale
through
a
broker)? 33 +Issue
date

N/A

N/A

Part 3 - Quotation of securities

You
need
only
complete
this
section
if
you
are
applying
for
quotation
of
securities

  • 34 Type
    of[+] securities ( tick
    one
    )

  • (a) +Securities
    described
    in
    Part
    1

(b)[All
other
][+][securities
] Example:
restricted
securities
at
the
end
of
the
escrowed
period,
partly
paid
securities
that
become
fully
paid, employee
incentive
share
securities
when
restriction
ends,
securities
issued
on
expiry
or
conversion
of
convertible securities

Entities that have ticked box 34(a)

**Additional

securities
forming
a
new
class
of
securities**

Tick
to
indicate
you
are
providing
the
information
or documents

35 If
the[+] securities
are[+] equity
securities,
the
names
of
the
20
largest
holders
of
the additional[+] securities,
and
the
number
and
percentage
of
additional[+] securities held
by
those
holders 36 If
the[+] securities
are[+] equity
securities,
a
distribution
schedule
of
the
additional +securities
setting
out
the
number
of
holders
in
the
categories 1
-­‐
1,000 1,001
-­‐
5,000 5,001
-­‐
10,000 10,001
-­‐
100,000 100,001
and
over

37 A
copy
of
any
trust
deed
for
the
additional[+] securities

Entities that have ticked box 34(b)

  • See
    chapter
    19
    for
    defined
    terms.

Appendix
3B
Page
6

38
Number of+securities for which
+quotation is sought



39
+Class of+securities for which
quotation is sought



40
Do the+securities rank equally in
all respects from the+issue date
with an existing+class of quoted
+securities?

If the additional+securities do
not rank equally, please state:
• the date from which they do
• the extent to which they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
• the extent to which they do
not rank equally, other than in
relation to the next dividend,
distribution
or
interest
payment

41 Reason
for
request
for
quotation now

Example:
In
the
case
of
restricted
securities,
end of
restriction
period

(if
issued
upon
conversion
of another[+] security,
clearly
identify that
other[+] security)

Number +Class

42 Number and +class of all +securities quoted on ASX ( including the[+] securities
in
clause 38)

**Quotation

agreement**

  • 1 +Quotation
    of
    our
    additional +securities
    is
    in
    ASX’s
    absolute
    discretion.
    ASX may
    quote
    the[+] securities
    on
    any
    conditions
    it
    decides.

  • 2 We
    warrant
    the
    following
    to
    ASX.

  • The
    issue
    of
    the[+] securities
    to
    be
    quoted
    complies
    with
    the
    law
    and
    is not
    for
    an
    illegal
    purpose.

  • There
    is
    no
    reason
    why
    those[+] securities
    should
    not
    be
    granted +quotation.

  • An
    offer
    of
    the[+] securities
    for
    sale
    within
    12
    months
    after
    their
    issue will
    not
    require
    disclosure
    under
    section
    707(3)
    or
    section
    1012C(6)
    of the
    Corporations
    Act.

Note:
An
entity
may
need
to
obtain
appropriate
warranties
from
subscribers
for
the
securities
in
order
to
be able
to
give
this
warranty

  • Section
    724
    or
    section
    1016E
    of
    the
    Corporations
    Act
    does
    not
    apply
    to any
    applications
    received
    by
    us
    in
    relation
    to
    any[+] securities
    to
    be quoted
    and
    that
    no-­‐one
    has
    any
    right
    to
    return
    any[+] securities
    to
    be quoted
    under
    sections
    737,
    738
    or
    1016F
    of
    the
    Corporations
    Act
    at
    the time
    that
    we
    request
    that
    the[+] securities
    be
    quoted.

  • If
    we
    are
    a
    trust,
    we
    warrant
    that
    no
    person
    has
    the
    right
    to
    return
    the +securities
    to
    be
    quoted
    under
    section
    1019B
    of
    the
    Corporations
    Act
    at the
    time
    that
    we
    request
    that
    the[+] securities
    be
    quoted.

  • 3 We
    will
    indemnify
    ASX
    to
    the
    fullest
    extent
    permitted
    by
    law
    in
    respect
    of
    any claim,
    action
    or
    expense
    arising
    from
    or
    connected
    with
    any
    breach
    of
    the warranties
    in
    this
    agreement.

  • 4 We
    give
    ASX
    the
    information
    and
    documents
    required
    by
    this
    form.

If
any information
or
document
is
not
available
now,
we
will
give
it
to
ASX
before +quotation
of
the +securities
begins.
We
acknowledge
that
ASX
is
relying
on the
information
and
documents.
We
warrant
that
they
are
(will
be)
true
and complete.

Sign
here: ............................................................
Date:
8
September
2014 ~~(Director/~~ Company
secretary)

Print
name: Matt
Vaughan

  • See
    chapter
    19
    for
    defined
    terms.

Appendix
3B
Page
8

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

==> picture [415 x 461] intentionally omitted <==

----- Start of picture text -----

Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid [+] ordinary
securities on issue 12 months before the
+issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid [+] ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary
securities cancelled during that 12 month
period
“A”
----- End of picture text -----

  • See
    chapter
    19
    for
    defined
    terms.

04/03/2013

Appendix
3B
Page
9

==> picture [415 x 635] intentionally omitted <==

----- Start of picture text -----

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used
Insert number of [+] equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C”
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
Subtract “C”
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C”
[Note: this is the remaining placement
capacity under rule 7.1]
----- End of picture text -----

  • See
    chapter
    19
    for
    defined
    terms.

Appendix
3B
Page
10

Part 2

==> picture [415 x 482] intentionally omitted <==

----- Start of picture text -----

Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply “A” by 0.10
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of [+] equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E”
----- End of picture text -----

  • See
    chapter
    19
    for
    defined
    terms.

04/03/2013

Appendix
3B
Page
11

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

“A” x 0.10 Note: number must be same as shown in Step 2 Subtract “E” Note: number must be same as shown in Step 3 Total [“A” x 0.10] – “E”

Note: this is the remaining placement capacity under rule 7.1A

  • See
    chapter
    19
    for
    defined
    terms. Appendix
    3B
    Page
    12